Engur, S. Et Al. 2016. Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.38, no.2 , 87-97.

Engur, S., DİKMEN, M., & ÖZTÜRK, Y., (2016). Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.38, no.2, 87-97.

Engur, Selin, MİRİŞ DİKMEN, And YUSUF ÖZTÜRK. "Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells," IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.38, no.2, 87-97, 2016

Engur, Selin Et Al. "Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells." IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.38, no.2, pp.87-97, 2016

Engur, S. DİKMEN, M. And ÖZTÜRK, Y. (2016) . "Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells." IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.38, no.2, pp.87-97.

@article{article, author={Selin Engur Et Al. }, title={Comparison of antiproliferative and apoptotic effects of a novel proteasome inhibitor MLN2238 with bortezomib on K562 chronic myeloid leukemia cells}, journal={IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY}, year=2016, pages={87-97} }